Pioglitazone increases non-esterified fatty acid clearance in upper body obesity
- 2 December 2005
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 49 (1) , 149-157
- https://doi.org/10.1007/s00125-005-0051-0
Abstract
Plasma NEFA concentrations are largely determined by adipose tissue lipolysis. Insulin suppression of lipolysis is commonly impaired with insulin resistance and improves with thiazolidinedione treatment of type 2 diabetes. The present studies were designed to assess the effects of thiazolidinedione on NEFA (oleate) metabolism that are independent of improved glycaemic control. We measured plasma oleate concentration and flux ([3H]oleate), glucose kinetics ([6-2H2]glucose) and substrate oxidation (indirect calorimetry) before and after pioglitazone (30 mg/day for ∼20 weeks) in 20 non-diabetic adults with upper body obesity. To assess the effects of improved insulin sensitivity per se we performed the same measurements in a matched group of volunteers treated with diet/exercise. Half of the two groups underwent these measurements during a hyperinsulinaemic–euglycaemic clamp, and the other half had their measurements taken during a (control) saline infusion before and after the intervention. Both interventions increased insulin-stimulated glucose disposal and reduced plasma oleate concentrations during the insulin clamp. After diet/exercise, oleate flux decreased (p=0.03) during the insulin clamp and oleate clearance remained unchanged (p=0.55), whereas in the pioglitazone group, oleate flux during the clamp was unchanged (p=0.97) and oleate clearance increased (p=0.003). Oleate clearance in the saline control condition was increased in the pioglitazone group compared with the diet/exercise group (p=0.02). In insulin-resistant, non-diabetic adults, pioglitazone increases NEFA clearance during physiological hyperinsulinaemia, whereas improved insulin sensitivity achieved by diet/exercise does not alter NEFA clearance but enhances insulin suppression of NEFA release. This action of pioglitazone may contribute to improved glucose metabolism in type 2 diabetes.Keywords
This publication has 45 references indexed in Scilit:
- Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation.Journal of Clinical Investigation, 1997
- Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.Journal of Clinical Investigation, 1996
- Gender differences in regional fatty acid metabolism before and after meal ingestion.Journal of Clinical Investigation, 1995
- Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.Journal of Clinical Investigation, 1995
- Mechanisms of fatty acid-induced inhibition of glucose uptake.Journal of Clinical Investigation, 1994
- Interaction between glucose and free fatty acid metabolism in human skeletal muscle.Journal of Clinical Investigation, 1993
- Regulation of forearm lipolysis in different types of obesity. In vivo evidence for adipocyte heterogeneity.Journal of Clinical Investigation, 1991
- Effects of Tolazamide and Exogenous Insulin on Insulin Action in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1986
- Studies of Human Adipose Tissue in Culture III INFLUENCE OF INSULIN AND MEDIUM GLUCOSE CONCENTRATION ON CELLULAR METABOLISMJournal of Clinical Investigation, 1974
- Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humansJournal of Clinical Investigation, 1970